Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center

CONCLUSION: Our IMID patients have a high rate of vaccination against SARS-CoV-2. Data show a significantly longer infection-free survival in vaccinated IMID patients as compared to unvaccinated patients. Discrimination between symptoms of COVID-19 and a concomitant inflammatory disease is difficult as complaints might be overlapping. This trial is registered with DRKS00028880.PMID:38571561 | PMC:PMC10990649 | DOI:10.1155/2024/6627035

Source: Autoimmune Diseases - April 4, 2024 Category: Allergy & Immunology Authors: Tobias Schlosser Marco Krasselt Louis Elsing Martin Hecker Babett Holler Albrecht Hoffmeister Source Type: research